0001493152-21-025084.txt : 20211008
0001493152-21-025084.hdr.sgml : 20211008
20211008203159
ACCESSION NUMBER: 0001493152-21-025084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211005
FILED AS OF DATE: 20211008
DATE AS OF CHANGE: 20211008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Malley Brendan M.
CENTRAL INDEX KEY: 0001884342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 211316434
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2021-10-05
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001884342
O'Malley Brendan M.
1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK
NY
10019
0
1
0
0
SVP, General Counsel
Common stock
2021-10-05
4
S
0
2447
1.0500
D
271007
D
Common stock
2021-10-08
4
S
0
22763
1.0506
D
248244
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.84 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
/s/ Brendan O'Malley
2021-10-08